- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04363606
Chronic Fatigue Etiology and Recovery in Covid-19 Patients: the Role of Fatigability (FatCovid-19)
Chronic Fatigue Etiology and Recovery in Covid-19 Patients : the Role of Fatigability and Stay in Intensive Care
Chronic fatigue is the most common and debilitating symptom in intensive care unit (ICU) survivors. Indeed, it has been widely reported that patients who stayed in ICU for prolonged periods report a feeling of tiredness for months to years after ICU discharge. This symptom seems particularly pronounced in Covid-19 patients and may affect their quality of life by decreasing their capacity to perform simple tasks of daily life.
The aim of the present project is to determine whether deteriorated neuromuscular function (i.e. increased fatigability) is involved in the feeling of fatigue of Covid-19 patients. Because the causes of this feeling are multi-dimensional, a large battery of tests will allow us to better understand the origin of chronic fatigue. A better knowledge of chronic fatigue etiology and its recovery will allow to optimize rehabilitation treatments to shorten the persistence of chronic fatigue and in fine improve life quality.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jérome MOREL, MD PhD
- Phone Number: +33 0477828553
- Email: jerome.morel@chu-st-etienne.fr
Study Locations
-
-
-
Grenoble, France
- Not yet recruiting
- CHU de Grenoble
-
Contact:
- Pierre BOUZAT, MD PhD
-
Principal Investigator:
- Pierre BOUZAT, MD PhD
-
Sub-Investigator:
- Renaud TAMISIER, MD PhD
-
Sub-Investigator:
- Stéphane DOUTRELEAU, MD PhD
-
Lyon, France
- Not yet recruiting
- Clinique de la Sauvegarde - Lyon
-
Contact:
- Olivier DESEBBE, MD
-
Principal Investigator:
- Olivier DESEBBE, MD
-
Lyon, France
- Not yet recruiting
- Hôpital Croix Rousse - HCL
-
Contact:
- Céline GUICHON, MD
-
Sub-Investigator:
- Céline GUICHON, MD
-
Sub-Investigator:
- Mélanie PRUDENT, MD
-
Sub-Investigator:
- Emeric STAUFFER, MD
-
Pierre-benite, France, 69310
- Recruiting
- Centre Hospitalier de Lyon Sud
-
Contact:
- Sébastien COURAUD, MD PhD
-
Principal Investigator:
- Sébastien COURAUD, MD PhD
-
Saint Etienne, France, 42055
- Recruiting
- CHU Saint-etienne
-
Sub-Investigator:
- Pascal GIRAUX, MD
-
Sub-Investigator:
- Lydia OUJAMAA, MD
-
Sub-Investigator:
- Marine Sorg, MD
-
Sub-Investigator:
- Léonard FEASSON, MD PhD
-
Sub-Investigator:
- Clément Foschia, MD
-
Sub-Investigator:
- Pierre CROISILLE, MD PhD
-
Contact:
- Jérome MOREL, MD PhD
- Phone Number: +33 (0)477828553
- Email: jerome.morel@chu-st-etienne.fr
-
Principal Investigator:
- Jérôme MOREL, MD PhD
-
Principal Investigator:
- Guillaume THIERY, MD PhD
-
Saint Etienne, France, 42100
- Not yet recruiting
- Clinique Mutualiste Saint Etienne
-
Contact:
- Vincent GAUTHIER, MD
-
Principal Investigator:
- Vincent GAUTHIER, MD
-
Saint-Genis-Laval, France, 69230
- Recruiting
- Hôpital Henry Gabrielle
-
Contact:
- Sophie JACQUIN-COURTOIS, MD PhD
-
Principal Investigator:
- Sophie JACQUIN-COURTOIS, MD PhD
-
Saint-Étienne, France, 42000
- Not yet recruiting
- Hôpital privé de la Loire
-
Principal Investigator:
- Laurent GERGELE, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria for patients who have been in intensive care :
- Diagnosed with Covid-19
- Ventilated in ICU for at least 3 consecutive days
- ICU discharge between 4 and 8 weeks
- Approval received from a physician
- Command of the French language
Inclusion Criteria for patients who have NOT been in intensive care :
- Diagnosed with Covid-19 : positive serological test or positive PCR test following nasopharyngeal swabbing
- Approval received from a physician
- Command of the French language
Exclusion Criteria:
- Taking neuroactive substances that can alter corticospinal excitability
- Patients with co-morbidities leading to significant fatigue: e.g. cancerous pathologies, sleep apnea
- Patients with neurodegenerative or neuromuscular disease
- Contraindication to the application of a magnetic field
- Contraindication to the practice of Magnetic Resonance Imaging
- Participant is pregnant
- Patients with psychiatric disorders
- Paraplegic and hemiplegic patients
- Addictive disorders
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: "Non-fatigued" patients who have been in intensive care units
|
Quality of life Depression Physical pain Social provisions Quality of sleep
complete blood count and cytokine concentration, TNF-alpha, LDL oxidized, AOPP, SOD, GPX, catalase, albumin, transthyretin, RBP, transferin, α-1 glycoprotein acide, ferritine, selenium, zinc, magnesium
The maximal effort test with VO2max recordings will be assessed during the first visit to the laboratory.
assessment of sleep quality
analyze the composition of the intestinal microbiote.
concerns only the patients of Saint Etienne
3 days of information to determine nutrient intakes.
concerns only the patients of Saint Etienne
|
Experimental: "Fatigued" patients who have been in intensive care units
|
Quality of life Depression Physical pain Social provisions Quality of sleep
complete blood count and cytokine concentration, TNF-alpha, LDL oxidized, AOPP, SOD, GPX, catalase, albumin, transthyretin, RBP, transferin, α-1 glycoprotein acide, ferritine, selenium, zinc, magnesium
The maximal effort test with VO2max recordings will be assessed during the first visit to the laboratory.
assessment of sleep quality
analyze the composition of the intestinal microbiote.
concerns only the patients of Saint Etienne
3 days of information to determine nutrient intakes.
concerns only the patients of Saint Etienne
|
Experimental: patients who have not been in intensive care units
|
Quality of life Depression Physical pain Social provisions Quality of sleep
complete blood count and cytokine concentration, TNF-alpha, LDL oxidized, AOPP, SOD, GPX, catalase, albumin, transthyretin, RBP, transferin, α-1 glycoprotein acide, ferritine, selenium, zinc, magnesium
The maximal effort test with VO2max recordings will be assessed during the first visit to the laboratory.
assessment of sleep quality
analyze the composition of the intestinal microbiote.
concerns only the patients of Saint Etienne
3 days of information to determine nutrient intakes.
concerns only the patients of Saint Etienne
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
voluntary maximum force reduction
Time Frame: 6 weeks post-discharge
|
6 weeks post-discharge
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Neuromuscular function : cortical activity
Time Frame: 6 weeks post-discharge
|
Level of cortical activation and cortico-spinal excitability measured by transcranial magnetic stimulation
|
6 weeks post-discharge
|
Neuromuscular function : Peripheral function
Time Frame: 6 weeks post-discharge
|
Peripheral function by electrical nerve stimulation
|
6 weeks post-discharge
|
Maximal oxygen uptake (VO2max)
Time Frame: 6 weeks post-discharge
|
measured by effort test
|
6 weeks post-discharge
|
quality of sleep
Time Frame: 6 weeks post-discharge
|
measured by actigraphy
|
6 weeks post-discharge
|
muscle volume
Time Frame: 6 weeks post-discharge
|
with Magnetic resonance imaging
|
6 weeks post-discharge
|
metabolic fatigue
Time Frame: 6 weeks post-discharge
|
measured by a Phosphorus 31 Nuclear magnetic resonance test
|
6 weeks post-discharge
|
microbiote intestinal
Time Frame: baseline and 6 months
|
stool analysis (concerns only the patients of Saint Etienne)
|
baseline and 6 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Jérome MOREL, MD PhD, CHU de Saint Etienne
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20CH085
- 2020-A00982-37 (Other Identifier: ANSM)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Fatigue Syndrome
-
Oslo University HospitalCompletedAdolescent Chronic Fatigue SyndromeNorway
-
Shanghai University of Traditional Chinese MedicineShanghai Yueyang Integrated Medicine HospitalRecruiting
-
Ho Cheol Shin, M.D., Ph.D.Green Cross Corporation; Ajou University School of Medicine; SymyooCompletedChronic Fatigue Syndrome | Idiopathic Chronic FatigueKorea, Republic of
-
AIM ImmunoTech Inc.Available
-
King Saud UniversityCompletedChronic Fatigue Syndrome (CFS)
-
Stony Brook UniversityCompletedChronic Fatigue Syndrome | Medically Unexplained Chronic FatigueUnited States
-
Centre Hospitalier Universitaire de Saint EtienneNot yet recruitingChronic Fatigue SyndromeFrance
-
Heilongjiang Quanle Pharmaceutical Co., Ltd.Not yet recruiting
-
King's College LondonSouth London and Maudsley NHS Foundation TrustNot yet recruiting
-
Power Life Sciences Inc.Not yet recruitingChronic Fatigue SyndromeUnited States
Clinical Trials on Questionnaires
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
Direction Centrale du Service de Santé des ArméesCompleted
-
Sun Yat-sen UniversityNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisRecruitingIntensive Care Unit Syndrome | Pediatric Post-intensive Care SyndromeFrance
-
University Hospital, GrenobleUniversity Grenoble AlpsNot yet recruitingChildhood Cancer | Adapted Physical ActivityFrance
-
M.D. Anderson Cancer CenterCompletedAdvanced Cancer | Malignant Neoplasms of Independent (Primary) Multiple SitesUnited States
-
The University of Hong KongCompleted
-
Centre Hospitalier Universitaire DijonCompleted
-
Cliniques universitaires Saint-Luc- Université...Fonds National de la Recherche ScientifiqueNot yet recruitingAlcohol Use Disorder
-
Memorial Sloan Kettering Cancer CenterIcahn School of Medicine at Mount Sinai; Hackensack Meridian Health; Derald H...CompletedLeukemia | Multiple Myeloma | Non-Hodgkin's Lymphoma | Hodgkin's DiseaseUnited States